LUMID Trademark

Trademark Overview


On Thursday, September 22, 2022, a trademark application was filed for LUMID with the United States Patent and Trademark Office. The USPTO has given the LUMID trademark a serial number of 97602709. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by SEED Therapeutics US, Inc.. The LUMID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug discovery services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials research; research and development of new products; providing scientific information, scientific, pharmaceutical, clinical, and medical research in the field of developing pharmaceutical drugs, drug discovery and development services, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell
lumid

General Information


Serial Number97602709
Word MarkLUMID
Filing DateThursday, September 22, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesPharmaceutical drug discovery services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials research; research and development of new products; providing scientific information, scientific, pharmaceutical, clinical, and medical research in the field of developing pharmaceutical drugs, drug discovery and development services, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 9, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEED Therapeutics US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Party NameSEED Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events


Event DateEvent Description
Monday, September 26, 2022NEW APPLICATION ENTERED
Sunday, October 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 5, 2023ASSIGNED TO EXAMINER
Friday, July 7, 2023NON-FINAL ACTION WRITTEN
Friday, July 7, 2023NON-FINAL ACTION E-MAILED
Friday, July 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 5, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 5, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, January 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 8, 2024SUSPENSION LETTER WRITTEN
Monday, January 8, 2024LETTER OF SUSPENSION E-MAILED
Monday, January 8, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 6, 2024TEAS STATEMENT OF USE RECEIVED